Showing 20 of 206 recruiting trials for “t-cell-prolymphocytic-leukemia”
A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
👨⚕️ Aimee C. Talleur, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Feb 2024View details ↗
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
RecruitingNCT06151730 ↗
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
CLL-IMPACT: A Clinical Nutrition Trial Investigating Immune and Metabolic Changes in Early-Stage CLL
👨⚕️ Maike Buchner-Mayr, PD Dr., Technisch Universität München📍 1 site📅 Started Jan 2024View details ↗
Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia
A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
RecruitingNCT06131801 ↗
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
👨⚕️ Lauren Pommert, MD, Children's Hospital Medical Center, Cincinnati📍 5 sites📅 Started Nov 2023View details ↗
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
RecruitingNCT06125795 ↗
A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain
Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia
Universal 4SCAR7U Targeting CD7-positive Malignancies
RecruitingNCT05809284 ↗
Determining the Mechanisms of Loss of CAR T Cell Persistence
👨⚕️ Persis Amrolia, BSc,MBBS,PhD, UCL Institute of Child Health📍 3 sites📅 Started Oct 2023View details ↗
A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →